CJC-1295 & GHRP-6 Blend (10mg) – Advanced Growth Hormone Research Peptide

The CJC-1295 & GHRP-6 Blend (10mg) is a highly researched peptide combination designed to explore growth hormone (GH) release mechanisms through complementary biological pathways. At Core Peptide USA, we supply research-grade peptide blends to laboratories and institutions across the United States, with a strong focus on purity, documentation, and responsible sourcing.

This peptide blend has gained significant attention in endocrine, metabolic, and regenerative research due to its synergistic action on growth hormone secretion. By combining a growth hormone–releasing hormone (GHRH) analog with a growth hormone secretagogue (GHS), researchers are able to study amplified and sustained GH signaling compared to single-pathway compounds.

👉 Learn more about our full catalog of research peptides on the
Core Peptide USA Research Peptides Collection:
https://corepeptide.us

What Is CJC-1295 & GHRP-6 Blend (10mg)?

The CJC-1295 & GHRP-6 Blend (10mg) consists of two synthetic peptides:

• CJC-1295 – a modified analog of growth hormone-releasing hormone (GHRH)

• GHRP-6 – a growth hormone-releasing hexapeptide and ghrelin analog

When combined, these peptides may stimulate GH release through distinct yet complementary receptor pathways, making the blend valuable in research models evaluating hormone pulsatility, anabolic signaling, and tissue repair mechanisms.

This blend is for laboratory and research use only and is not approved for human or veterinary consumption.

Understanding GHRP-6 in Research

GHRP-6 is a synthetic six-amino-acid peptide structurally distinct from ghrelin but capable of binding to the growth hormone secretagogue receptor (GHS-R1a). Researchers classify GHRP-6 within the GHS family due to its ability to stimulate GH release independent of GHRH pathways.

Unlike opioid peptides with similar structures, GHRP-6 does not appear to exhibit opioid activity, making it especially interesting in endocrine and metabolic studies. Research suggests GHRP-6 may also interact with CD36 receptors, which are involved in fat metabolism, inflammation signaling, angiogenesis, and immune modulation.

For deeper molecular data, see the PubChem summary for GHRP-6:
https://pubchem.ncbi.nlm.nih.gov/compound/9919153

Understanding CJC-1295 in Research

CJC-1295, also known as tetra-substituted GRF (1-29), is a synthetic analog of the first 29 amino acids of endogenous GHRH. It includes four strategic amino acid substitutions designed to improve stability and resistance to enzymatic degradation.

These substitutions occur at positions 2, 8, 15, and 27 and are believed to enhance bioactivity while preserving strong affinity for GHRH receptors. Researchers study CJC-1295 for its ability to induce pulsatile growth hormone secretion, a key factor in downstream IGF-1 signaling.

More compound details can be found via the National Center for Biotechnology Information (NCBI):
https://pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC

Why Combine CJC-1295 & GHRP-6?

The CJC-1295 & GHRP-6 Blend (10mg) is designed to explore synergistic GH release, as each peptide activates different regulatory mechanisms:

• CJC-1295 stimulates pituitary GH release via GHRH receptors

• GHRP-6 suppresses somatostatin inhibition and activates GHS receptors

Clinical research suggests that when GHRH analogs and GHRPs are used together, GH output may be significantly greater than when either peptide is studied alone. This makes the blend particularly valuable in research focused on:

• Growth hormone pulsatility

• IGF-1 signaling pathways

• Tissue repair and regeneration models

• Metabolic and endocrine regulation

Molecular Composition (Research Reference)

CJC-1295

• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂

• Molecular Weight: 3367.9 g/mol

GHRP-6

• Molecular Formula: C₄₆H₅₆N₁₂O₆

• Molecular Weight: 873.0 g/mol

These molecular characteristics contribute to the peptides’ stability and receptor affinity in laboratory settings.

Research Highlights and Study Insights

Published studies indicate that CJC-1295 may increase growth hormone levels multiple-fold compared to placebo, with effects persisting for days following exposure. GHRP-6 has been independently shown to stimulate GH release across multiple age groups and experimental conditions.

Research involving combined GHRH and GHRP administration suggests enhanced GH response even in cases where hormonal regulation is impaired, such as hypothyroid or metabolically stressed models.

One notable clinical study published in the Journal of Clinical Endocrinology & Metabolism reported sustained GH elevation following continuous CJC-1295 stimulation:
https://pubmed.ncbi.nlm.nih.gov/17018654/

Why Buy from Core Peptide USA?

At CorePeptide.us, we specialize in high-purity research peptides for laboratories across the United States. Our CJC-1295 & GHRP-6 Blend (10mg) is:

• Independently tested for purity

• Properly labeled for research compliance

• Shipped discreetly within the USA

• Backed by transparent sourcing standards

We understand the needs of researchers seeking consistency, documentation, and reliability when sourcing peptide compounds.

Explore related growth hormone research peptides here:
https://corepeptide.us/collections/peptides